Latest Options News

Leeuwin Metals has rapidly transformed into a formidable Western Australian gold explorer by acquiring the Marda Gold Project, completing its maiden drilling program, and securing $3.25 million in fresh capital. Historical data and early drilling hint at significant high-grade gold potential.

Axiom Properties reported a $200,000 cash reserve decline to $1.658 million for Q1 2025, driven by strong growth in its PaySure business and a pending $7.6 million land sale from its Mount Barker development.

Peako Limited reports a quiet quarter in East Kimberley exploration due to seasonal conditions but successfully completes a significant capital raise, bolstering its cash position to nearly A$2 million.

DataWorks Group Limited has secured a two-year extension on its BetStop self-exclusion contract and is advancing its global RegTech pipeline, aiming for positive operating cash flow by December 2025.

Invert Graphite has lodged a prospectus to raise up to A$3.5 million through a share offer priced at A$0.03 each, while advancing its acquisition of a Tanzanian critical minerals project. The company reported no exploration activity this quarter and incurred operating losses, reflecting a transitional phase ahead of relisting.

Western Gold Resources has made significant strides in advancing its Gold Duke Project, securing a preferred mining contractor with a deferred payment facility and raising over $1.7 million in capital to support development towards production.

Orpheus Uranium Limited has fortified its Australian uranium portfolio by acquiring the Pirie Basin Project and raising $1.25 million to fund upcoming exploration, positioning itself strongly in key uranium provinces.

Moab Minerals reports robust uranium mineralisation from its Manyoni Project in Tanzania and progresses exploration in Colorado’s Uravan Belt, supported by a recent $500k capital raise.

Far Northern Resources has secured approval for a major drilling program at Bridge Creek and submitted a renewal for its Empire mining lease, maintaining a robust cash position after modest exploration spending in Q1 2025.

Core Energy Minerals has expanded its uranium portfolio with key South Australian acquisitions and secured $3.7 million in funding, setting the stage for maiden drilling at the Cummins Project.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Westar Resources wraps up low-grade drilling at Mindoolah, opts out of acquisition, while progressing exploration at Gidgee North with promising geophysical targets and pending assay results.